Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | UNG | P13051 | 1/20 | 0.61 |
| ▸ | P4HB | P07237 | 3/20 | 0.57 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.57 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.57 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.57 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.57 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.57 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.57 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.57 |
| ▸ | ERN1 | O75460 | 3/20 | 0.55 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.55 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29677467 | 1.00 | ALDH1A1 (0.61) | ALDH1A1UNGP4HBGRIN2DGRIN3B | |
| 3-Formylbenzoic Acid SCHEMBL6558253 | 0.93 | UNG (0.74) | ALDH1A1UNGP4HBGRIN2DGRIN3B | |
| SCHEMBL31013334 | 0.90 | ERN1 (0.65) | ALDH1A1UNGP4HBGRIN2DGRIN3B | |
| SCHEMBL5861135 | 0.90 | ERN1 (0.65) | ALDH1A1UNGP4HBGRIN2DGRIN3B | |
| SCHEMBL18546896 | 0.89 | ALDH1A1 (0.51) | ALDH1A1UNGP4HBGRIN2DGRIN3B | |
| SCHEMBL29903423 | 0.88 | ALDH1A1 (0.49) | ALDH1A1UNGP4HBGRIN2DGRIN3B | |
| SCHEMBL4955281 | 0.87 | L3MBTL1 (0.53) | ALDH1A1UNGP4HBGRIN2DGRIN3B | |
| SCHEMBL4407110 | 0.87 | P4HB (0.68) | ALDH1A1P4HBGRIN2DGRIN3BGRIN1 | |
| SCHEMBL11456160 | 0.87 | P4HB (0.59) | ALDH1A1P4HBGRIN2DGRIN3BGRIN1 | |
| SCHEMBL11222093 | 0.87 | P4HB (0.68) | ALDH1A1P4HBGRIN2DGRIN3BGRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117296850-B | Medicine for repelling or fumigating tobacco nails and application thereof | 浙江大学 | 2025-04-25 | — | — | CN | claimed |
| CN-114920667-B | Electrochemical preparation method of atta Lu Lunzhi | 湖南大学 | 2024-06-21 | — | — | CN | claimed |
| CN-117683038-A | Preparation method of tetraphenylporphyrin compound | 中国石化扬子石油化工有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117617252-A | Application of 3-formaldehyde methyl benzoate in prevention and treatment of tobacco beetles | 福建中烟工业有限责任公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117296850-A | Medicine for repelling or fumigating tobacco nails and application thereof | 浙江大学 | 2023-12-29 | — | — | CN | claimed |
| CN-114920667-A | Electrochemical preparation method of astraglucol | 湖南大学 | 2022-08-19 | — | — | CN | claimed |
| CN-113480764-B | Preparation method of enhanced polyvinyl alcohol antibacterial film and product thereof | 贵州省材料产业技术研究院 | 2021-12-24 | — | — | CN | claimed |
| CN-113480764-A | Preparation method of enhanced polyvinyl alcohol antibacterial film and product thereof | 贵州省材料产业技术研究院 | 2021-10-08 | — | — | CN | claimed |
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | L'OREAL S.A. | 2007-06-14 | — | — | US | claimed |
| US-7204857-B1 | Dyeing method using a specific active methylene compound and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL S.A. (FR) | 2007-04-17 | — | — | US | claimed |
| US-20030092634-A1 | Novel compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. | 2003-05-15 | — | — | US | claimed |
| US-6506733-B1 | Which process comprises hydrogenating a compound of Formula 9: presence of a catalytic amount of 20% palladium hydroxide on carbon. | AXYS PHARMACEUTICALS, INC. | 2003-01-14 | — | — | US | claimed |
| US-6458168-B1 | Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative | L'OREAL S.A. (FR) | 2002-10-01 | — | — | US | claimed |
| US-6451067-B1 | HAIR DYE MIXTURE | L'OREAL S.A. (FR) | 2002-09-17 | — | — | US | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1159260-A1 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | claimed |
| WO-2000055124-A2 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| WO-1991018861-A1 | 2-(HYDROXYMETHYL) ACRYLATE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1991-12-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | KRT18, NDUFB5, NDUFB7 | ALDH1A1 83/4885UNG 2513/4885P4HB 715/4885 |
| US-20030092634-A1 | Novel compounds and compositions as protease inhibitors | SERPINB1, HPN, CTRL | ALDH1A1 3641/4885UNG 1146/4885P4HB 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.